Danaher Corporation (DHR)vsMettler-Toledo International Inc (MTD)
DHR
Danaher Corporation
$236.95
+1.23%
HEALTHCARE · Cap: $161.01B
MTD
Mettler-Toledo International Inc
$1,698.47
+0.78%
HEALTHCARE · Cap: $32.84B
Smart Verdict
WallStSmart Research — data-driven comparison
Danaher Corporation generates 507% more annual revenue ($25.11B vs $4.13B). MTD leads profitability with a 21.9% profit margin vs 16.0%. DHR appears more attractively valued with a PEG of 1.32. DHR earns a higher WallStSmart Score of 66/100 (B-).
DHR
Strong Buy66
out of 100
Grade: B-
MTD
Buy64
out of 100
Grade: C+
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 59.7% YoY
Large-cap with strong market position
Generating 1.6B in free cash flow
Strong operational efficiency at 31.2%
Safe zone — low bankruptcy risk
Every $100 of equity generates 30 in profit
Keeps 22 of every $100 in revenue as profit
Areas to Watch
Premium valuation, high expectations priced in
Premium valuation, high expectations priced in
4.5% revenue growth
Expensive relative to growth rate
Trading at 2653.9x book value
Comparative Analysis Report
WallStSmart ResearchBull Case : DHR
The strongest argument for DHR centers on EPS Growth, Market Cap, Free Cash Flow. Profitability is solid with margins at 16.0% and operating margin at 19.8%. PEG of 1.32 suggests the stock is reasonably priced for its growth.
Bull Case : MTD
The strongest argument for MTD centers on Operating Margin, Altman Z-Score, Return on Equity. Profitability is solid with margins at 21.9% and operating margin at 31.2%.
Bear Case : DHR
The primary concerns for DHR are P/E Ratio. A P/E of 40.8x leaves little room for execution misses.
Bear Case : MTD
The primary concerns for MTD are P/E Ratio, Revenue Growth, PEG Ratio. Debt-to-equity of 164.70 is elevated, increasing financial risk.
Key Dynamics to Monitor
DHR profiles as a mature stock while MTD is a value play — different risk/reward profiles.
MTD carries more volatility with a beta of 1.19 — expect wider price swings.
DHR is growing revenue faster at 5.5% — sustainability is the question.
DHR generates stronger free cash flow (1.6B), providing more financial flexibility.
Bottom Line
DHR scores higher overall (66/100 vs 64/100), backed by strong 16.0% margins. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Danaher Corporation
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company's 3 platforms are Life Sciences, Diagnostics, and Environmental & Applied Solutions.
Mettler-Toledo International Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Mettler Toledo (NYSE: MTD) is a multinational manufacturer of scales and analytical instruments. It is the largest provider of weighing instruments for use in laboratory, industrial, and food retailing applications. The company also provides various analytical instruments, process analytics instruments, and end-of-line inspection systems.
Visit Website →Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?